New OWEAR Program Highlights Emerging De Facto Standards in Open-source Algorithms
The Open Wearables Initiative (OWEAR) announced a new program designed to identify and support open-source algorithms that are being adopted rapidly and may become de facto industry standards.
This OWEAR program uses the number and quality of references to “crowdsource” the identification of potential de facto standards. Once a potential standard is identified, OWEAR will create and maintain a searchable catalog that displays key information about the studies in which the algorithm has been employed, including the therapeutic area, population(s) studied, and number of participants.
OWEAR plans to create a new catalog for each open-source algorithm used in a wearable sensor or other connected health technology that generates more than 25 published papers and meets other quality metrics. The reference-count criterion indicates that the algorithm has garnered significant industry adoption. Shimmer Research, Inc. has agreed to donate the staff time to create and maintain these OWEAR catalogs.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
